Centiva Capital’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$413K Sell
25,000
-1,110
-4% -$18.3K ﹤0.01% 1011
2026
Q1
$425K Buy
26,110
+1,110
+4% +$17.4K ﹤0.01% 912
2025
Q4
$371K Buy
+25,000
New +$353K ﹤0.01% 800
2024
Q1
Sell
-23,968
Closed -$303K 2198
2023
Q4
$303K Buy
23,968
+5,204
+28% +$65.7K 0.01% 1192
2023
Q3
$255K Sell
18,764
-3,686
-16% -$56.9K 0.01% 1269
2023
Q2
$385K Sell
22,450
-1,401
-6% -$21.7K 0.01% 967
2023
Q1
$332K Buy
+23,851
New +$351K 0.01% 1011

Other funds holding SEM

Centiva Capital's SEM Position: Q2 2026 in Review

Centiva Capital reduced its Select Medical (SEM) stake by 4.3% in Q2 2026, selling an estimated $18.3K and leaving 25,000 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #1011.

Centiva Capital first reported a position in SEM in Q1 2023 and has held it in 7 quarters since. The position peaked at $425K in Q1 2026. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

  • Centiva Capital held 25,000 shares of Select Medical worth $413K as of Q2 2026.
  • Centiva Capital sold 1,110 Select Medical shares in Q2 2026, an estimated $18.3K.
  • Select Medical made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1011 holding.
  • Centiva Capital first reported a position in Select Medical in Q1 2023 and has held it in 7 quarters since.
  • Centiva Capital's Select Medical position peaked at $425K in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.